Last update 21 Nov 2024

AO-252

Overview

Basic Info

Drug Type
Chemical drugs
Synonyms
Target
TACC3
Mechanism
TACC3 inhibitors(Transforming acidic coiled protein 3 inhibitors)
Therapeutic Areas
NeoplasmsEndocrinology and Metabolic DiseaseSkin and Musculoskeletal Diseases+ [1]
Active Indication
Endometrial CarcinomaOvarian CancerTriple Negative Breast Cancer+ [1]
Inactive Indication-
Originator Organization
OncoCube Therapeutics LLCA2a Pharmaceuticals, Inc.A2a Pharmaceuticals, Inc.Startup
Active Organization
A2a Pharmaceuticals, Inc.A2a Pharmaceuticals, Inc.StartupOncoCube Therapeutics LLC
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with AO-252
NCT06136884 / RecruitingPhase 1
A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors
100 Clinical Results associated with AO-252
Login to view more data
100 Translational Medicine associated with AO-252
Login to view more data
100 Patents (Medical) associated with AO-252
Login to view more data
100 Deals associated with AO-252
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Endometrial CarcinomaPhase 1
US
A2a Pharmaceuticals, Inc.A2a Pharmaceuticals, Inc.Startup
02 Nov 2023
Ovarian CancerPhase 1
US
A2a Pharmaceuticals, Inc.A2a Pharmaceuticals, Inc.Startup
02 Nov 2023
Triple Negative Breast CancerPhase 1
US
A2a Pharmaceuticals, Inc.A2a Pharmaceuticals, Inc.Startup
02 Nov 2023
Solid tumorPreclinical
US
OncoCube Therapeutics LLC
17 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free